Ancora Advisors’s TNF Pharmaceuticals, Inc. Common Stock TNFA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1
| Closed | -$215 | – | 1885 |
|
|
2024
Q1 | $215 | Hold |
1
| – | – | ﹤0.01% | 1681 |
|
|
2023
Q4 | $698 | Hold |
1
| – | – | ﹤0.01% | 1530 |
|
|
2023
Q3 | $1.6K | Hold |
1
| – | – | ﹤0.01% | 1466 |
|
|
2023
Q2 | $4.05K | Hold |
1
| – | – | ﹤0.01% | 1378 |
|
|
2023
Q1 | $4.64K | Hold |
1
| – | – | ﹤0.01% | 1377 |
|
|
2022
Q4 | $3K | Hold |
1
| – | – | ﹤0.01% | 1521 |
|
|
2022
Q3 | $7K | Hold |
1
| – | – | ﹤0.01% | 1546 |
|
|
2022
Q2 | $6K | Hold |
1
| – | – | ﹤0.01% | 1680 |
|
|
2022
Q1 | $13K | Hold |
1
| – | – | ﹤0.01% | 1633 |
|
|
2021
Q4 | $16K | Hold |
1
| – | – | ﹤0.01% | 1639 |
|
|
2021
Q3 | $19K | Hold |
1
| – | – | ﹤0.01% | 1474 |
|
|
2021
Q2 | $17K | Hold |
1
| – | – | ﹤0.01% | 1378 |
|
|
2021
Q1 | $17K | Buy |
+1
| New | +$17K | ﹤0.01% | 1312 |
|